CreditAccess Grameen (CAGL) continued to deliver industry-leading performance as reflected in Q3FY23 RoA / RoE at 4.6% / 18.8%, respectively - surpassing pre-covid level. Notably, Board approval for the extension of Mr. Udaya Kumar Hebbar as MD & CEO for another 2 years, post the expiry of his current term on June’23 (subject to shareholder approval), would ensure management continuity at the top.